Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 475

1.

Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection.

Bentur L, Gur M, Ashkenazi M, Livnat-Levanon G, Mizrahi M, Tal A, Ghaffari A, Geffen Y, Aviram M, Efrati O.

J Cyst Fibros. 2019 May 22. pii: S1569-1993(19)30104-3. doi: 10.1016/j.jcf.2019.05.002. [Epub ahead of print]

2.

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.

Rom O, Xu G, Guo Y, Zhu Y, Wang H, Zhang J, Fan Y, Liang W, Lu H, Liu Y, Aviram M, Liu Z, Kim S, Liu W, Wang X, Chen YE, Villacorta L.

EBioMedicine. 2019 Mar;41:62-72. doi: 10.1016/j.ebiom.2019.02.019. Epub 2019 Feb 13.

3.

Exogenous (Pomegranate Juice) or Endogenous (Paraoxonase1) Antioxidants Decrease Triacylglycerol Accumulation in Mouse Cardiovascular Disease-Related Tissues.

Rom O, Volkova N, Jeries H, Grajeda-Iglesias C, Aviram M.

Lipids. 2018 Nov;53(11-12):1031-1041. doi: 10.1002/lipd.12112. Epub 2018 Dec 17.

PMID:
30560569
4.

Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age.

Shteinberg M, Lulu AB, Downey DG, Blumenfeld Z, Rousset-Jablonski C, Perceval M, Colombo A, Stein N, Livnat G, Gur M, Bentur L, Mussaffi H, Blau H, Sarouk I, Dagan A, Kerem E, Aviram M, Picard E, Aliberti S, Álvarez A, Miranda JP, Polverino E, Durieu I, Stuart Elborn J, Cohen-Cymberknoh M.

J Cyst Fibros. 2019 Jul;18(4):525-529. doi: 10.1016/j.jcf.2018.10.009. Epub 2018 Oct 23.

PMID:
30366850
5.

Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.

Rom O, Villacorta L, Zhang J, Chen YE, Aviram M.

Curr Opin Lipidol. 2018 Oct;29(5):428-432. doi: 10.1097/MOL.0000000000000543. No abstract available.

PMID:
30153136
6.

Pulmonary involvement in Niemann-Pick C type 1.

Staretz-Chacham O, Aviram M, Morag I, Goldbart A, Hershkovitz E.

Eur J Pediatr. 2018 Nov;177(11):1609-1615. doi: 10.1007/s00431-018-3219-6. Epub 2018 Jul 31.

PMID:
30066180
7.

Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article.

Grajeda-Iglesias C, Aviram M.

Rambam Maimonides Med J. 2018 Jul 30;9(3). doi: 10.5041/RMMJ.10337. Review.

8.

Pro-atherogenic and pro-oxidant crosstalk between adipocytes and macrophages.

Nimri L, Grajeda-Iglesias C, Volkova N, Aviram M.

Eur J Nutr. 2019 Mar;58(2):879-893. doi: 10.1007/s00394-018-1729-7. Epub 2018 May 26.

PMID:
29804185
9.

Branched-chain amino acids and atherosclerosis: friends or foes?

Grajeda-Iglesias C, Rom O, Aviram M.

Curr Opin Lipidol. 2018 Apr;29(2):166-169. doi: 10.1097/MOL.0000000000000494. No abstract available.

PMID:
29517610
10.

An International Genetic Survey of Breed-Specific Diseases in Working Dogs from the United States, Israel, and Poland.

Shaffer LG, Ramirez CJ, Phelps P, Aviram M, Walczak M, Bar-Gal GK, Ballif BC.

Cytogenet Genome Res. 2017;153(4):198-204. doi: 10.1159/000486774. Epub 2018 Feb 9.

PMID:
29421799
11.

Leucine supplementation attenuates macrophage foam-cell formation: Studies in humans, mice, and cultured macrophages.

Grajeda-Iglesias C, Rom O, Hamoud S, Volkova N, Hayek T, Abu-Saleh N, Aviram M.

Biofactors. 2018 May;44(3):245-262. doi: 10.1002/biof.1415. Epub 2018 Feb 5.

12.

Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.

Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, De Boeck K, Barbato A, Snijders D, Collura M, Pradal U, Blau H, Mussaffi H, Price M, Bentur L, Gur M, Aviram M, Picard E, Shteinberg M, Livnat G, Rivlin J, Hiller N, Shoseyov D, Amirav I, Kerem E.

Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.

PMID:
28947038
13.

Slfn2 mutation-induced loss of T-cell quiescence leads to elevated de novo sterol synthesis.

Omar I, Rom O, Aviram M, Cohen-Daniel L, Gebre AK, Parks JS, Berger M.

Immunology. 2017 Nov;152(3):484-493. doi: 10.1111/imm.12785. Epub 2017 Aug 2.

14.

Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.

Behar DM, Inbar O, Shteinberg M, Gur M, Mussaffi H, Shoseyov D, Ashkenazi M, Alkrinawi S, Bormans C, Hakim F, Mei-Zahav M, Cohen-Cymberknoh M, Dagan A, Prais D, Sarouk I, Stafler P, Bar Aluma BE, Akler G, Picard E, Aviram M, Efrati O, Livnat G, Rivlin J, Bentur L, Blau H, Kerem E, Singer A.

Mol Genet Genomic Med. 2017 Feb 19;5(3):223-236. doi: 10.1002/mgg3.278. eCollection 2017 May.

15.

Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: a key role for triglyceride metabolism.

Rom O, Grajeda-Iglesias C, Najjar M, Abu-Saleh N, Volkova N, Dar DE, Hayek T, Aviram M.

J Nutr Biochem. 2017 Jul;45:24-38. doi: 10.1016/j.jnutbio.2017.02.023. Epub 2017 Apr 6.

PMID:
28431321
16.

High-density lipoprotein-associated paraoxonase 1: a possible prognostic biomarker for heart failure?

Rom O, Aviram M.

Eur J Heart Fail. 2017 Jun;19(6):756-759. doi: 10.1002/ejhf.817. Epub 2017 Mar 31. No abstract available.

17.

Resveratrol fails to provide prophylactic protection in a rat model of organophosphate poisoning.

Rosman Y, Ravfogel S, Shiyovich A, Shrot S, Milk N, Ophir N, Aviram M, Nir I, Kassirer M, Eisenkraft A.

Disaster Mil Med. 2016 Jul 26;2:11. doi: 10.1186/s40696-016-0021-8. eCollection 2016.

18.

It is not just lipids: proatherogenic vs. antiatherogenic roles for amino acids in macrophage foam cell formation.

Rom O, Aviram M.

Curr Opin Lipidol. 2017 Feb;28(1):85-87. doi: 10.1097/MOL.0000000000000377. No abstract available.

PMID:
28030455
19.

Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities.

Amirav I, Roduta Roberts M, Mussaffi H, Mandelberg A, Roth Y, Abitbul R, Luder A, Blau H, Alkrinawi S, Aviram M, Ben-Ami M, Rotschild M, Bentur L, Shoseyov D, Cohen-Cymberknoh M, Kerem E, Avital A, Springer C, Hevroni A, Dabbah H, Elizur A, Picard E, Goldberg S, Rivlin J, Livnat G, Lavie M, Alias N, Soferman R, Olbrich H, Raidt J, Wallmeier J, Werner C, Loges NT, Omran H.

Version 2. F1000Res. 2016 Aug 18 [revised 2016 Jan 1];5:2031. eCollection 2016.

20.

Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice.

Rom O, Korach-Rechtman H, Hayek T, Danin-Poleg Y, Bar H, Kashi Y, Aviram M.

Arch Toxicol. 2017 Apr;91(4):1709-1725. doi: 10.1007/s00204-016-1859-8. Epub 2016 Sep 30.

PMID:
27696135
21.

Primary ciliary dyskinesia in Israel: Prevalence, clinical features, current diagnosis and management practices.

Abitbul R, Amirav I, Blau H, Alkrinawi S, Aviram M, Shoseyov D, Bentur L, Avital A, Springer C, Lavie M, Prais D, Dabbah H, Elias N, Elizur A, Goldberg S, Hevroni A, Kerem E, Luder A, Roth Y, Cohen-Cymberknoh M, Ben Ami M, Mandelberg A, Livnat G, Picard E, Rivlin J, Rotschild M, Soferman R, Loges NT, Olbrich H, Werner C, Wolter A, Herting M, Wallmeier J, Raidt J, Omran H, Mussaffi H.

Respir Med. 2016 Oct;119:41-47. doi: 10.1016/j.rmed.2016.08.015. Epub 2016 Aug 23.

22.
23.

Nitro-Oleic Acid Reduces J774A.1 Macrophage Oxidative Status and Triglyceride Mass: Involvement of Paraoxonase2 and Triglyceride Metabolizing Enzymes.

Rosenblat M, Rom O, Volkova N, Aviram M.

Lipids. 2016 Aug;51(8):941-53. doi: 10.1007/s11745-016-4169-2. Epub 2016 Jun 25.

PMID:
27344666
24.

Paraoxsonase2 (PON2) and oxidative stress involvement in pomegranate juice protection against cigarette smoke-induced macrophage cholesterol accumulation.

Rom O, Aviram M.

Chem Biol Interact. 2016 Nov 25;259(Pt B):394-400. doi: 10.1016/j.cbi.2016.05.009. Epub 2016 May 6.

PMID:
27163848
25.

Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.

Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, Rivlin J, Gur M, Shteinberg M, Bentur L, Livnat G, Aviram M, Picard E, Tenenbaum A, Armoni S, Breuer O, Shoseyov D, Kerem E.

J Cyst Fibros. 2016 Nov;15(6):776-782. doi: 10.1016/j.jcf.2016.04.006. Epub 2016 May 1.

26.

Aqueous or lipid components of atherosclerotic lesion increase macrophage oxidation and lipid accumulation.

Abu-Saleh N, Aviram M, Hayek T.

Life Sci. 2016 Jun 1;154:1-14. doi: 10.1016/j.lfs.2016.04.019. Epub 2016 Apr 23.

PMID:
27114099
27.

Pomegranate Juice Polyphenols Induce Macrophage Death via Apoptosis as Opposed to Necrosis Induced by Free Radical Generation: A Central Role for Oxidative Stress.

Rom O, Volkova N, Nandi S, Jelinek R, Aviram M.

J Cardiovasc Pharmacol. 2016 Aug;68(2):106-14. doi: 10.1097/FJC.0000000000000391.

PMID:
27010808
28.

Paraoxonase 1 (PON1) and pomegranate influence circadian gene expression and period length.

Loizides-Mangold U, Koren-Gluzer M, Skarupelova S, Makhlouf AM, Hayek T, Aviram M, Dibner C.

Chronobiol Int. 2016;33(4):453-61. doi: 10.3109/07420528.2016.1154067. Epub 2016 Mar 24.

PMID:
27010443
29.

Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression.

Burillo E, Tarin C, Torres-Fonseca MM, Fernandez-García CE, Martinez-Pinna R, Martinez-Lopez D, Llamas-Granda P, Camafeita E, Lopez JA, Vega de Ceniga M, Aviram M, Egido J, Blanco-Colio LM, Martín-Ventura JL.

Clin Sci (Lond). 2016 Jun 1;130(12):1027-38. doi: 10.1042/CS20160185. Epub 2016 Mar 18.

PMID:
26993251
30.

Endogenous or exogenous antioxidants vs. pro-oxidants in macrophage atherogenicity.

Rom O, Aviram M.

Curr Opin Lipidol. 2016 Apr;27(2):204-6. doi: 10.1097/MOL.0000000000000287. No abstract available.

PMID:
26959710
31.

DNAH11 Localization in the Proximal Region of Respiratory Cilia Defines Distinct Outer Dynein Arm Complexes.

Dougherty GW, Loges NT, Klinkenbusch JA, Olbrich H, Pennekamp P, Menchen T, Raidt J, Wallmeier J, Werner C, Westermann C, Ruckert C, Mirra V, Hjeij R, Memari Y, Durbin R, Kolb-Kokocinski A, Praveen K, Kashef MA, Kashef S, Eghtedari F, Häffner K, Valmari P, Baktai G, Aviram M, Bentur L, Amirav I, Davis EE, Katsanis N, Brueckner M, Shaposhnykov A, Pigino G, Dworniczak B, Omran H.

Am J Respir Cell Mol Biol. 2016 Aug;55(2):213-24. doi: 10.1165/rcmb.2015-0353OC.

32.

Novel Osteogenic Ti-6Al-4V Device For Restoration Of Dental Function In Patients With Large Bone Deficiencies: Design, Development And Implementation.

Cohen DJ, Cheng A, Kahn A, Aviram M, Whitehead AJ, Hyzy SL, Clohessy RM, Boyan BD, Schwartz Z.

Sci Rep. 2016 Feb 8;6:20493. doi: 10.1038/srep20493.

33.

Human carotid atherosclerotic plaque protein(s) change HDL protein(s) composition and impair HDL anti-oxidant activity.

Cohen E, Aviram M, Khatib S, Volkova N, Vaya J.

Biofactors. 2016 Jan-Feb;42(1):115-28. doi: 10.1002/biof.1254. Epub 2015 Dec 11.

PMID:
26662883
34.

The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening.

Stafler P, Mei-Zahav M, Wilschanski M, Mussaffi H, Efrati O, Lavie M, Shoseyov D, Cohen-Cymberknoh M, Gur M, Bentur L, Livnat G, Aviram M, Alkrinawi S, Picard E, Prais D, Steuer G, Inbar O, Kerem E, Blau H.

J Cyst Fibros. 2016 Jul;15(4):460-6. doi: 10.1016/j.jcf.2015.08.007. Epub 2015 Sep 16.

35.

Selective oxidative stress and cholesterol metabolism in lipid-metabolizing cell classes: Distinct regulatory roles for pro-oxidants and antioxidants.

Rosenblat M, Volkova N, Aviram M.

Biofactors. 2015 Jul-Aug;41(4):273-88. doi: 10.1002/biof.1223. Epub 2015 Jul 30.

PMID:
26228307
36.

Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring.

Yitshak-Sade M, Gorodischer R, Aviram M, Novack L.

J Clin Pharmacol. 2016 Jan;56(1):116-23. doi: 10.1002/jcph.574. Epub 2015 Aug 10.

PMID:
26096778
37.

High intrinsic aerobic capacity and pomegranate juice are protective against macrophage atherogenecity: studies in high- vs. low-capacity runner (HCR vs. LCR) rats.

Rosenblat M, Volkova N, Abassi Z, Britton SL, Koch LG, Aviram M.

J Nutr Biochem. 2015 Oct;26(10):1015-21. doi: 10.1016/j.jnutbio.2015.04.001. Epub 2015 May 6.

38.

Effects of Pomegranate Extract Supplementation on Cardiovascular Risk Factors and Physical Function in Hemodialysis Patients.

Wu PT, Fitschen PJ, Kistler BM, Jeong JH, Chung HR, Aviram M, Phillips SA, Fernhall B, Wilund KR.

J Med Food. 2015 Sep;18(9):941-9. doi: 10.1089/jmf.2014.0103. Epub 2015 Mar 31.

PMID:
25826143
39.

Anti-atherogenic properties of date vs. pomegranate polyphenols: the benefits of the combination.

Rosenblat M, Volkova N, Borochov-Neori H, Judeinstein S, Aviram M.

Food Funct. 2015 May;6(5):1496-509. doi: 10.1039/c4fo00998c.

PMID:
25811166
40.

Antioxidant and antiatherogenic properties of phenolic acid and flavonol fractions of fruits of 'Amari' and 'Hallawi' date (Phoenix dactylifera L.) varieties.

Borochov-Neori H, Judeinstein S, Greenberg A, Volkova N, Rosenblat M, Aviram M.

J Agric Food Chem. 2015 Apr 1;63(12):3189-95. doi: 10.1021/jf506094r. Epub 2015 Mar 24.

PMID:
25765921
41.

Colorimetric polymer assay for the diagnosis of plasma lipids atherogenic quality in hypercholesterolemic patients.

Mann E, Kolusheva S, Yossef R, Porgador A, Aviram M, Jelinek R.

Mol Diagn Ther. 2015 Feb;19(1):35-43. doi: 10.1007/s40291-014-0127-y.

PMID:
25680504
42.

Pomegranate juice polyphenols induce a phenotypic switch in macrophage polarization favoring a M2 anti-inflammatory state.

Aharoni S, Lati Y, Aviram M, Fuhrman B.

Biofactors. 2015 Jan-Feb;41(1):44-51. doi: 10.1002/biof.1199. Epub 2015 Feb 4.

PMID:
25650983
43.

Human carotid atherosclerotic lesion protein components decrease cholesterol biosynthesis rate in macrophages through 3-hydroxy-3-methylglutaryl-CoA reductase regulation.

Cohen E, Aviram M, Khatib S, Rosenblat M, Vaya J.

Biofactors. 2015 Jan-Feb;41(1):28-34. doi: 10.1002/biof.1196. Epub 2015 Jan 30.

PMID:
25639207
44.

In vitro effects of exogenous carbon monoxide on oxidative stress and lipid metabolism in macrophages.

Petrick L, Rosenblat M, Aviram M.

Toxicol Ind Health. 2016 Jul;32(7):1318-23. doi: 10.1177/0748233714558084. Epub 2014 Dec 11.

PMID:
25501254
45.

Silicon dioxide nanoparticles increase macrophage atherogenicity: Stimulation of cellular cytotoxicity, oxidative stress, and triglycerides accumulation.

Petrick L, Rosenblat M, Paland N, Aviram M.

Environ Toxicol. 2016 Jun;31(6):713-23. doi: 10.1002/tox.22084. Epub 2014 Nov 28.

PMID:
25448404
46.

HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.

Rosenblat M, Volkova N, Aviram M.

Biofactors. 2014 Sep-Oct;40(5):536-45. doi: 10.1002/biof.1184. Epub 2014 Sep 18.

PMID:
25230879
47.

Reduced glutathione increases quercetin stimulatory effects on HDL- or apoA1-mediated cholesterol efflux from J774A.1 macrophages.

Rosenblat M, Volkova N, Khatib S, Mahmood S, Vaya J, Aviram M.

Free Radic Res. 2014 Dec;48(12):1462-72. doi: 10.3109/10715762.2014.963574. Epub 2014 Oct 7.

PMID:
25204422
48.

Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL.

Cohen E, Aviram M, Khatib S, Artoul F, Rabin A, Mannheim D, Karmeli R, Salamon T, Vaya J.

Free Radic Biol Med. 2014 Nov;76:14-24. doi: 10.1016/j.freeradbiomed.2014.07.036. Epub 2014 Aug 1.

PMID:
25091896
49.

Oxidative stress and nephrolithiasis: a comparative pilot study evaluating the effect of pomegranate extract on stone risk factors and elevated oxidative stress levels of recurrent stone formers and controls.

Tracy CR, Henning JR, Newton MR, Aviram M, Bridget Zimmerman M.

Urolithiasis. 2014 Oct;42(5):401-8. doi: 10.1007/s00240-014-0686-8. Epub 2014 Aug 2.

PMID:
25085198
50.

Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study.

Hamoud S, Hayek T, Volkova N, Attias J, Moscoviz D, Rosenblat M, Aviram M.

Atherosclerosis. 2014 Jan;232(1):204-10. doi: 10.1016/j.atherosclerosis.2013.11.037. Epub 2013 Nov 19.

PMID:
24401239

Supplemental Content

Loading ...
Support Center